Anxiety, Depression and Perception of the Quality of Life in the Patient with HIV/AIDS
Keywords:
human immunodeficiency virus, acquired immunodeficiency syndrome, quality of life, anxiety, depression
Abstract
Infection with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) as a complication is now considered a chronic disease and, although mortality and morbidity have been significantly reduced, the psychosocial impact of the disease generates painful consequences in the patient reflected in anxiety and depression. The concept of quality of life is global, multidisciplinary, and involves objective and subjective aspects. Health-related quality of life involves functioning and physical symptoms, psychological factors and social aspects. The interest of this review lies in the social impact of HIV, not only in relation to the economic and political repercussions for treatment and prevention, but also in the identification of variables related to the improvement of the quality of life of people with HIV. There is a great interest in the study of quality of life of patients with HIV / AIDS, and research has shown that there is a relationship between quality of life and psychological variables such as anxiety and depression, as well as biological parameters such as CD4 lymphocyte levels and the viral load that could perhaps be considered in health decisions and in interventions that promote protection and welfare factors. The implementation of interventions aimed at improving the quality of life of patients with HIV / AIDS throughout the evolutionary period of infection is very important.Downloads
Download data is not yet available.
References
Protto JP, Schaaf D, Fidel Suárez M. Entorno epidemiológico y respuesta a la epidemia del VIH en Bolivia. Rev. Panam. Salud Pública. 2008; 23:4 288-294.
World Health Organization (WHO). Salud mental: un estado de bienestar. [Online] 2013. Available from: HYPERLINK http://www.who.int/features/factfiles/mental_health/es/
Wagner G, Kanouse D, Koegel P. Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care. 2004; 16: 501–506.
Benjet C, Borges G, Medina-Mora M, Fleitz-Bautista C. La depresión con inicio temprano: prevalencia, curso natural y latencia para buscar tratamiento. Salud Pública Méx. 2004; 46: 417–4.
Boletín de la ANMM. El trastorno de ansiedad generalizada. Rev. Fac. Med. 2013; 56: 53-55.
O’Connel K, Skevington K, Saxena S, WHOQOL HIV Group. Preliminary development of the world Health Organization’s Quality of Life HIV instrument (WHOQOL HIV): analysis of the pilot version. Soc. Sci. Med. 2003; 57: 1259-75.
Martín I, Cano R, Pérez de Ayala P, Aguayo M. Calidad de vida, aspectos psicológicos y sociales en pacientes con infección VIH avanzada. An. Med. Interna. 2002; 19: 20-28.
Rosales L, Ponce S, Rodríguez-Álvarez M. La situación actual del VIH/SIDA en el mundo. Gac. Méd. Méx. 2010; 146:408-10.
Velez H, Rojas W, Borrero J, Restrepo J. Manual de VIH/SIDA y otras infecciones de Transmisión Sexual. In. Colombia: Corporación para investigaciones biológicas; 2011; 7-18.
Bautista Arredondo S, Romero Martínez M, Conde C. Resultados principales de la encuesta de sero-prevalencia en sitios de encuentro de hombres que tienen sexo con hombres México: Letra S, Sida, Cultura y Vida Cotidiana A.C.; 2013; 15-38.
Torres Fermán IA et al. La salud mental, una aproximación a su estudio en poblaciones vulnerables. Med. Salud Soc. 2013; 3: 1-33.
World Health Organization (WHO). Recommendations on the diagnosis of HIV infection in infants and children. Available from http://www.who.int/hiv/pub/. 2012; paediatric/diagnosis/en/index.html.
Organización Panamericana de la Salud (OPS). Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud (CEI-10). OPS. OMS. 1992.
Jurado S, Villegas E, Méndez La estandarización del Inventario de Depresión de Beck para los residentes de la ciudad de México. Salud Ment. 1998; 21: 26–32
Asch S K. Underdiagnosis of HIV. Who are we missing? Gen. Inter. Med. 2003; 18: 450-60.
Wolff C, M. RA, Wolff R. M. Prevalencia, factores de riesgo y manejo de la depresión en pacientes con infección por VIH. Rev. Chil 7 Infect. 2010; 27: 65-74.
Cook J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am. J. Public Health 2004; 94: 1133-1140.
Trépanier LL, Rourke SB, Bayoumi AM, Halman MH, Krzyzanowski S, Power C. The impact of neuropsychological impairment and depression on health-related quality of life in HIV-infection. J. Clin. Exp. Neuropsychol. 2005; 27:1-15
Jin H, et al. Depression and suicidality in HIV/AIDS in China. J. Affect Disord. 2006; 94: 269-75.
Treisman GA, Angelino A. Interrelation between psychiatric disorders and the prevention and treatment of HIV infection. Clin. Infect. Dis. 2007; 45: 313-317.
Olantunji B, Mimiaga MJ, O’Cleirigh C, Safren SA. A review of treatment studies of depression in HIV. Top HIV Med. 2006; 14: 112-24.
Academia, Española Real. Diccionario de la lengua española In Madrid SA. Madrid: (22nd ed.); 2001.
Boletín de la ANMM. El trastorno de ansiedad generalizada. Rev. Fac. Med. UNAM. 2012; 21(3): 1-2.
Testal J, Calderon CS, Garcelán SP. From DSM-IV-TR to DSM-5: analysis of some changes. Int. J. Clin. Health Psicol. 2014; 14:221-231.
Steer RA, Clark DA, Beck AT, Ranieri WF. Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA. Behav. Res. Ther. 1999;37:183-90.
Rovira MD, Uriz E, Rodríguez C, Vila A. Comportamiento y actitud de los profesionales de enfermería hospitalaria ante los pacientes VIH positivos. Enfermería Clin. 1993; 4: 135-141.
Lederman J, et al. Progression to AIDS, a clinical AIDS condition and mortality: Psychosocial and physiological predictors. Psychol. Med. 2002; 32: 1059-1073.
Safren S, Gershuny BS, Hendriksen E. Symptoms of posttraumatic stress and death anxiety in persons with HIV and medication adherence difficulties. AIDS Patien. Care STDS 2003; 17: 657-664.
Miller AK, Lee BL, Henderson CE. Death anxiety in persons with HIV/AIDS: A systematic review and meta-analysis. Death Stud. 2012; 36: 640-663.
Ntshakala TT, Mavundla TR, Dolamo BL. Quality of life domains relevant to people living with HIV and AIDS who are on antiretroviral therapy in Swaziland. Curationis 2012; 35(1):87.
Douaihy A, Singh N. Factors affecting quality of life in patients with HIV infection. AIDS Read. 2001; 11:450-461.
Ruvalcaba N, Salazar J, Fernández-Berrocal F. Indicadores sociales, condiciones de vida y calidad de vida en jóvenes mexicanos. Rev. Iberoamer. Psicol. Cien. Tecnol. 2012; 5: 71–80
Vinaccia S, et al. Calidad de vida, Personalidad resistente y apoyo social percibido en pacientes con diagnóstico de Cáncer de Pulmón. Psicol. Salud. 2005; 15: 207–221.
Trépanier LL, Rourke SB, Bayoumi AM, Halman MH, Krzyzanowski S, Power C. The impact of neuropsychological impairment and depression on health-related quality of life in HIV-infection. J. Clin. Exp. Neuropsychol. 2005; 27:1-15.
ONUSIDA. La Epidemia de SIDA. Situación en diciembre de 2006. Programa conjunto de las naciones unidad sobre VIH/SIDA. 2006; 4-94.
Ruiz Perez I, et al. Health-related quality of life of patients with HIV: impact of sociodemographic, clinical and psychosocial factors. Qual Life Res. 2005; 14:1301-10.
González-Puente JA, Sánchez-Sosa JJ.. Systematic assessment of quality of life in HIV patients at three clinical stages of the infection. J. Clin. Health Psychol. 2001; 1:519-528.
World Health Organization (WHO). Salud mental: un estado de bienestar. [Online] 2013. Available from: HYPERLINK http://www.who.int/features/factfiles/mental_health/es/
Wagner G, Kanouse D, Koegel P. Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care. 2004; 16: 501–506.
Benjet C, Borges G, Medina-Mora M, Fleitz-Bautista C. La depresión con inicio temprano: prevalencia, curso natural y latencia para buscar tratamiento. Salud Pública Méx. 2004; 46: 417–4.
Boletín de la ANMM. El trastorno de ansiedad generalizada. Rev. Fac. Med. 2013; 56: 53-55.
O’Connel K, Skevington K, Saxena S, WHOQOL HIV Group. Preliminary development of the world Health Organization’s Quality of Life HIV instrument (WHOQOL HIV): analysis of the pilot version. Soc. Sci. Med. 2003; 57: 1259-75.
Martín I, Cano R, Pérez de Ayala P, Aguayo M. Calidad de vida, aspectos psicológicos y sociales en pacientes con infección VIH avanzada. An. Med. Interna. 2002; 19: 20-28.
Rosales L, Ponce S, Rodríguez-Álvarez M. La situación actual del VIH/SIDA en el mundo. Gac. Méd. Méx. 2010; 146:408-10.
Velez H, Rojas W, Borrero J, Restrepo J. Manual de VIH/SIDA y otras infecciones de Transmisión Sexual. In. Colombia: Corporación para investigaciones biológicas; 2011; 7-18.
Bautista Arredondo S, Romero Martínez M, Conde C. Resultados principales de la encuesta de sero-prevalencia en sitios de encuentro de hombres que tienen sexo con hombres México: Letra S, Sida, Cultura y Vida Cotidiana A.C.; 2013; 15-38.
Torres Fermán IA et al. La salud mental, una aproximación a su estudio en poblaciones vulnerables. Med. Salud Soc. 2013; 3: 1-33.
World Health Organization (WHO). Recommendations on the diagnosis of HIV infection in infants and children. Available from http://www.who.int/hiv/pub/. 2012; paediatric/diagnosis/en/index.html.
Organización Panamericana de la Salud (OPS). Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud (CEI-10). OPS. OMS. 1992.
Jurado S, Villegas E, Méndez La estandarización del Inventario de Depresión de Beck para los residentes de la ciudad de México. Salud Ment. 1998; 21: 26–32
Asch S K. Underdiagnosis of HIV. Who are we missing? Gen. Inter. Med. 2003; 18: 450-60.
Wolff C, M. RA, Wolff R. M. Prevalencia, factores de riesgo y manejo de la depresión en pacientes con infección por VIH. Rev. Chil 7 Infect. 2010; 27: 65-74.
Cook J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am. J. Public Health 2004; 94: 1133-1140.
Trépanier LL, Rourke SB, Bayoumi AM, Halman MH, Krzyzanowski S, Power C. The impact of neuropsychological impairment and depression on health-related quality of life in HIV-infection. J. Clin. Exp. Neuropsychol. 2005; 27:1-15
Jin H, et al. Depression and suicidality in HIV/AIDS in China. J. Affect Disord. 2006; 94: 269-75.
Treisman GA, Angelino A. Interrelation between psychiatric disorders and the prevention and treatment of HIV infection. Clin. Infect. Dis. 2007; 45: 313-317.
Olantunji B, Mimiaga MJ, O’Cleirigh C, Safren SA. A review of treatment studies of depression in HIV. Top HIV Med. 2006; 14: 112-24.
Academia, Española Real. Diccionario de la lengua española In Madrid SA. Madrid: (22nd ed.); 2001.
Boletín de la ANMM. El trastorno de ansiedad generalizada. Rev. Fac. Med. UNAM. 2012; 21(3): 1-2.
Testal J, Calderon CS, Garcelán SP. From DSM-IV-TR to DSM-5: analysis of some changes. Int. J. Clin. Health Psicol. 2014; 14:221-231.
Steer RA, Clark DA, Beck AT, Ranieri WF. Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA. Behav. Res. Ther. 1999;37:183-90.
Rovira MD, Uriz E, Rodríguez C, Vila A. Comportamiento y actitud de los profesionales de enfermería hospitalaria ante los pacientes VIH positivos. Enfermería Clin. 1993; 4: 135-141.
Lederman J, et al. Progression to AIDS, a clinical AIDS condition and mortality: Psychosocial and physiological predictors. Psychol. Med. 2002; 32: 1059-1073.
Safren S, Gershuny BS, Hendriksen E. Symptoms of posttraumatic stress and death anxiety in persons with HIV and medication adherence difficulties. AIDS Patien. Care STDS 2003; 17: 657-664.
Miller AK, Lee BL, Henderson CE. Death anxiety in persons with HIV/AIDS: A systematic review and meta-analysis. Death Stud. 2012; 36: 640-663.
Ntshakala TT, Mavundla TR, Dolamo BL. Quality of life domains relevant to people living with HIV and AIDS who are on antiretroviral therapy in Swaziland. Curationis 2012; 35(1):87.
Douaihy A, Singh N. Factors affecting quality of life in patients with HIV infection. AIDS Read. 2001; 11:450-461.
Ruvalcaba N, Salazar J, Fernández-Berrocal F. Indicadores sociales, condiciones de vida y calidad de vida en jóvenes mexicanos. Rev. Iberoamer. Psicol. Cien. Tecnol. 2012; 5: 71–80
Vinaccia S, et al. Calidad de vida, Personalidad resistente y apoyo social percibido en pacientes con diagnóstico de Cáncer de Pulmón. Psicol. Salud. 2005; 15: 207–221.
Trépanier LL, Rourke SB, Bayoumi AM, Halman MH, Krzyzanowski S, Power C. The impact of neuropsychological impairment and depression on health-related quality of life in HIV-infection. J. Clin. Exp. Neuropsychol. 2005; 27:1-15.
ONUSIDA. La Epidemia de SIDA. Situación en diciembre de 2006. Programa conjunto de las naciones unidad sobre VIH/SIDA. 2006; 4-94.
Ruiz Perez I, et al. Health-related quality of life of patients with HIV: impact of sociodemographic, clinical and psychosocial factors. Qual Life Res. 2005; 14:1301-10.
González-Puente JA, Sánchez-Sosa JJ.. Systematic assessment of quality of life in HIV patients at three clinical stages of the infection. J. Clin. Health Psychol. 2001; 1:519-528.
Published
2018-01-05
How to Cite
Salazar Campos, A., & Valencia Ortiz, A. I. (2018). Anxiety, Depression and Perception of the Quality of Life in the Patient with HIV/AIDS. Mexican Journal of Medical Research ICSA, 6(11). https://doi.org/10.29057/mjmr.v6i11.2985
Section
Articles
